Clinical Trial Update: Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating vaccine therapy using sargramostim (GM-CSF) in patients with HER2-positive stage III-IV breast cancer or ovarian cancer has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Drugs mentioned

• Leukine (sargramostim) (sargramostim)

Snippet

Sponsor: University of Washington | Conditions: HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer | Phase 1 | Status: COMPLETED